Search This Blog

Monday, 13 January 2014

Policy, pharmacology and the European Association of Clinical Pharmacology and Therapeutics

The EACPT is in a prime position to foster an environment of exchange between research and policy within the field of clinical pharmacology and therapeutics.

the national scientific and professional organisations and societies for clinical pharmacology and therapeutics in Europe. It aims to provide educational and scientific support for the more than 4,000 individual professionals interested in clinical pharmacology and therapeutics throughout the European region.

All medicines have risks of adverse effects, in addition to their expected health benefits. The EACPT is very well placed to provide up-to-date briefings and recommendations to policy makers on how pharmacology can contribute positively to human health and wealth, through a clear understanding of the clinical and cost benefit/risk ratio of medicines.

The EACPT is also in a strong position to advise on the support needed for clinical pharmacology and therapeutics, and its underpinning pharmacology, to ensure that established experts and emerging CPT professionals in academia, the clinical domain, governance, industry and other roles can continue to develop and use medicines effectively to meet current and new challenges to human health.

For more information on the Policy Community journal where this article was published please visit